U.S. Stock News

Vertex Pharmaceuticals (NasdaqGS:VRTX) has secured a reimbursement agreement in Germany for its CASGEVY gene therapy for sickle cell disease and beta thalassemia. This is Germany's first long term access deal for a gene edited therapy of this kind, supporting broader patient access within the country. The agreement expands CASGEVY access in Europe and adds to Vertex's efforts to build revenue beyond its cystic fibrosis portfolio. For investors tracking NasdaqGS:VRTX, the new German...

In the first quarter of 2026, Centene Corporation reported revenue of US$49.94 billion and net income of US$1.54 billion, with diluted EPS from continuing operations of US$3.11, all higher than a year earlier. Alongside these results, Centene raised its 2026 guidance, lifting expected total revenue to between US$187.50 billion and US$191.50 billion and increasing its GAAP diluted EPS outlook to above US$2.37, signaling management’s confidence in ongoing margin and cost initiatives. We’ll now...

In late April 2026, JANA Partners sent a letter to Markel Group’s board urging a divestiture of Markel Ventures and a US$2.00 billion share repurchase tender, while questioning incentive payouts and arguing that the Ventures segment has diluted the value of the core insurance business. This activist push brings Markel’s long-standing “forever home” pledge to acquired businesses into direct tension with shareholder priorities around capital allocation and corporate structure. We’ll now...

In late April 2026, Varonis Systems reported first-quarter revenue of US$173.13 million, a similar loss per share as a year earlier, completed a US$149.99 million buyback program, and issued guidance calling for double-digit revenue growth for the second quarter and full year 2026. At the same time, Varonis highlighted surging demand for its AI and data security platform, including new ENS High certification in Spain and stronger SaaS adoption, reinforcing its role in securing the data that...

White Mountains Insurance Group reported first-quarter 2026 results showing revenue of US$517.8 million and a net loss of US$27.2 million, reversing a profit a year earlier as investment losses pushed basic and diluted loss per share from continuing operations to US$12.59. Beneath the headline loss, the company’s Ark/WM Outrigger insurance operations produced strong underwriting results, while a large unrealized loss on its MediaAlpha stake and a 1% decline in book value per share...

Viking Holdings (NYSE:VIK) opened bookings for its expanded 2028–2029 expedition voyages. The company added new departure dates and extra sailings in the Arctic, Antarctica, and the Great Lakes. The move widens Viking's expedition footprint across remote and cold-weather destinations. Viking Holdings, listed as NYSE:VIK, focuses on premium cruises, including ocean, river, and expedition offerings. The decision to expand expedition sailings in 2028 and 2029 in the Arctic, Antarctica, and the...

Hims & Hers Health (HIMS) heads into its May 11 earnings report under closer watch as investors weigh margin concerns, rising competitive and legal pressures, and recent board changes that reshape the company’s governance profile. See our latest analysis for Hims & Hers Health. Short term sentiment has cooled, with a 1 day share price return showing a decline of 4.58% and a 7 day share price return showing a decline of 5.59%. However, the 30 day share price return of 31.54% and multi year...

In early May 2026, Arista Networks reported first-quarter revenue of US$2,709 million and net income of US$1,022.9 million, and guided second-quarter revenue to about US$2.8 billion while raising its full-year 2026 revenue outlook to roughly US$11.5 billion despite industry-wide supply constraints pressuring margins. The results underscored how surging demand for Arista’s AI-focused networking platforms, including its 7800 AI spine and universal AI fabric offerings, is helping the company...

In early May 2026, attention turned to PagSeguro Digital as analysts anticipated year-over-year increases in earnings per share and revenue for the March 2026 quarter, even as earnings estimates were revised slightly lower. This mix of expected operational improvement and cautious analyst revisions has put extra focus on how reliably PagSeguro can translate growth into consistent performance versus forecasts. With analysts expecting higher earnings and revenue despite slightly lower...

If you are wondering whether Adobe's current share price really reflects what the stock could be worth, this breakdown will help you weigh up the numbers behind that question. Adobe closed at US$256.51, with returns of 4.2% over the last week and 6.8% over the last month, while the year-to-date return stands at a 23.0% decline and the 1-year return at a 33.2% decline. Recent moves in the stock sit alongside ongoing attention on Adobe's position in creative software and digital media, as...

Rocket Companies (RKT) closed FY 2025 with fourth quarter revenue of US$2.8b, basic EPS of US$0.02 and net income of US$68.0m, setting a clear marker for how the year wrapped up. Over recent periods the company has seen quarterly revenue move from US$1.9b in Q4 2024 to US$2.8b in Q4 2025, while basic EPS shifted from US$0.23 to US$0.02, and net income moved from US$33.5m to US$68.0m. This provides a clear view of how the top and bottom lines translated into current margins and overall...

Innodata (INOD) just wrapped up FY 2025 with fourth quarter revenue of US$72.4 million and basic EPS of US$0.28, while trailing twelve month revenue came in at US$251.7 million and basic EPS at US$1.01. Over recent quarters the company has seen revenue move from US$59.2 million in Q4 2024 to US$72.4 million in Q4 2025, with basic EPS shifting from US$0.34 to US$0.28 over the same period. This sets up a picture where growth expectations and margin trends will be front of mind for investors...

If you are wondering whether Millrose Properties at around US$26.90 still offers value, the starting point is to understand what the current price implies about the business. The stock is up 14.1% over the last year, even though it has seen a 12.3% decline over the past week and a 3.0% decline over the past month, with a 9.8% decline year to date. This may have shifted how some investors think about its risk and reward trade off. Recent coverage has focused on Millrose Properties as a...

ArcBest (ARCB) stock was in focus after first quarter earnings showed sales of US$998.79 million and a net loss of US$1.04 million, with management highlighting stable demand despite winter weather and fuel headwinds. See our latest analysis for ArcBest. The Q1 update and ongoing buybacks have come against a backdrop of strong share price momentum, with a year to date share price return of 57.81% and a 1 year total shareholder return of 96.13%. The recent 7 day share price pullback of 4.54%...

CSX (CSX) is back in focus after it and Canadian Pacific Kansas City overhauled their Southeast Mexico Express premium rail service, which cut transit times and expanded cross-border reach between the U.S. Southeast, Texas and Mexico. See our latest analysis for CSX. The upgraded Southeast Mexico Express service lands at a time when CSX’s 1 month share price return of 7.34% and year to date share price return of 22.58% sit alongside a 1 year total shareholder return of 55.86%. This suggests...

Capital Clean Energy Carriers (CCEC) has just wrapped up FY 2025 with fourth quarter revenue of US$86.8 million and basic EPS of US$0.46. Trailing 12 month EPS came in at US$1.92 as earnings over that period were very large compared with the prior year. The company has seen revenue on a trailing 12 month basis move from US$339.5 million in FY 2024 to US$392.7 million in FY 2025. Over the same period, EPS shifted from US$0.13 to US$1.92 and net profit margin moved from 2.2% to 28.9%. These...

Genworth Financial reported past first-quarter 2026 results with revenue of US$1,777 million and net income of US$47 million, alongside modestly lower earnings per share year over year. The company also completed a sizeable share repurchase program and highlighted Enact’s contribution and the build-out of CareScout as key parts of its longer-term plan. Next, we will examine how Genworth’s continued share repurchases shape the company’s investment narrative and its appeal to different...

GPGI (GPGI) is drawing fresh attention after first quarter 2026 results combined record sales at CompoSecure with a US$235 million net loss and weaker Husky performance, along with a new international commercial leadership appointment. See our latest analysis for GPGI. The first quarter loss and Husky headwinds have coincided with sharp share price weakness, with a 1 day share price return of negative 25.9% and a 90 day share price return of negative 47.1%. However, the 3 year total...

If you are wondering whether DENTSPLY SIRONA stock is starting to look interesting at current levels, its recent price and valuation signals give you a lot to think about. The share price sits at US$10.96 after a 6.7% decline over the last week, a 4.9% decline over the last month and a 28.5% decline over the last year, which may change how you view both its risk and potential reward. Recent coverage around DENTSPLY SIRONA has focused on its position within the medical equipment space and how...

Repligen (RGEN) is back in focus after its first quarter 2026 earnings, where profit topped market expectations, full year adjusted earnings guidance moved higher, and the stock gained 7.3% on the news. See our latest analysis for Repligen. Beyond the post earnings jump, Repligen’s 7 day share price return of 6.86% and 30 day share price return of 9.66% sit against a year to date share price decline of 23.07%. The 1 year total shareholder return of a 1.11% decline and 3 year total shareholder...

What Crane’s latest earnings and M&A comments mean for investors Crane (CR) just paired a Q1 earnings beat with a slight uptick in full year adjusted EPS guidance, yet a softer operating margin and active acquisition agenda are shaping how investors reassess the stock. See our latest analysis for Crane. Crane’s recent Q1 earnings beat, slight full year EPS guidance increase, dividend affirmation, and active M&A commentary come after a 1 year total shareholder return of 7.6%. The 3 year total...

In early May 2026, Clean Harbors, Inc. reported first-quarter 2026 results showing revenue of US$1,459.54 million and net income of US$63.2 million, and issued full-year 2026 GAAP net income guidance of US$421 million to US$472 million. The quarter also featured record safety performance, strong landfill volume growth tied to PFAS and project work, and higher full-year adjusted EBITDA guidance supported by operational efficiency initiatives, including AI deployment and new field service...

Recently, Legend Biotech expanded its scientific advisory board with six leading experts in oncology and cell therapy and, together with Janssen, agreed to increase CARVYKTI manufacturing capacity at Janssen’s Raritan, New Jersey facility to support its cell therapy ambitions. This combination of deeper scientific guidance and scaled manufacturing marks a meaningful step in Legend’s efforts to build an end-to-end cell therapy platform targeting high unmet medical needs. We’ll now examine how...

In the first quarter of 2026, First Solar reported sales of US$1,044.24 million and net income of US$346.62 million, with basic earnings per share from continuing operations of US$3.23, all higher than a year earlier. Alongside these results, the company reaffirmed its 2026 outlook, including expected module volumes of 17.0–18.2 GW and net sales of US$4.90–US$5.20 billion, reinforcing visibility into its order book and manufacturing plans. Building on this earnings strength and reaffirmed...